Please login to the form below

Not currently logged in
Email:
Password:

drug recall

This page shows the latest drug recall news and features for those working in and with pharma, biotech and healthcare.

Sun Pharma recalls antidepressant in US

Sun Pharma recalls antidepressant in US

India-based Sun Pharmaceutical Industries is to recall more than 40, 000 bottles of an antidepressant after the drug was discovered to have problems dissolving in the body. ... US regulator the FDA announced the recall of venlafaxine hydrochloride last

Latest news

  • Pfizer recalls depression drug in US Pfizer recalls depression drug in US

    Pfizer recalls depression drug in US. Wrong medicine found in bottle of Effexor XR. ... The company also warned of potential contraindications and drug-drug interactions that patients may have if they mistakenly take Tikosyn.

  • FDA suspends sale of Ariad’s cancer drug FDA suspends sale of Ariad’s cancer drug

    FDA suspends sale of Ariad’ s cancer drug. Iclusig linked to increased risk of blood clots. ... The US Food and Drug Administration (FDA) has asked Ariad to suspend sales of its leukaemia drug Iclusig as it continues to investigate reports of

  • Novo Nordisk recalls insulin Novo Nordisk recalls insulin

    Diabetes patients in Europe were warned to be on alert after Novo Nordisk announced a recall of several batches of its NovoMix insulin. ... We are working closely with national health authorities to ensure patient safety and minimise the disruption this

  • Communications rethink for Health Canada Communications rethink for Health Canada

    Committing to doing an additional assessment of the impact of a drug recall on Canadians, in addition to the health risk assessments currently done according to internationally recognised scientific standards. ... The review has provided timely and

  • Affymax in a tailspin after Omontys recall Affymax in a tailspin after Omontys recall

    Affymax in a tailspin after Omontys recall. Makes heavy job cuts in face of bankruptcy threat. ... Affymax is slashing three quarters of its workforce and could be facing bankruptcy in the wake of the recall last month of kidney disease drug Omontys, its

More from news
Approximately 4 fully matching, plus 15 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics